Rob Berkeley

Rob Berkeley has a diverse work experience in the field of science and medicine. Rob started their career as a Research Scientist at the University of Leicester, where they conducted short-term projects related to tuberculosis and lipid metabolism. Rob then worked as a Research Assistant at Durham University, focusing on cancer cell migration and the pathophysiology of Alzheimer's disease. Rob earned a Bachelor of Science (BSc) degree in Cell Biology from Durham University, where they achieved first-class honors and was selected to represent the School of Biological Sciences at a research symposium.

After that, Rob pursued a PhD in Medicine (Oncology) at the University of Leeds, where they conducted research on oncolytic viruses as anti-cancer agents. Their project focused on the interaction between oncolytic reovirus and antiviral antibodies, as well as the delivery of the virus by monocyte cells. Rob presented their work at various symposia and conferences.

Currently, Rob holds a position at Envision Pharma Group, starting as an Associate Medical Writer and progressing to Medical Writer and Senior Medical Writer. Rob is currently working as a Scientific Director at the company. The exact dates for their roles at Envision Pharma Group are not provided.

Rob Berkeley has a strong educational background in the field of medicine and oncology. Rob obtained a Doctor of Philosophy - PhD degree from the University of Leeds, focusing on medicine (oncology), between the years 2014 and 2018. Prior to that, they completed their undergraduate studies at Durham University from 2010 to 2014, where they earned a BSc degree in Cell Biology. Rob's education journey began at Leicester Grammar School from 2003 to 2010, where they completed their A-levels in Biology (A*), Chemistry (A*), and Geography (A). Rob also achieved an AS-level in Mathematics (A).